Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review

Intrahepatic lymphoepithelioma-like cholangiocarcinoma (LELCC) is a very rare malignant tumor arising from the biliary epithelium. To date, there has been a lack of evidence on the radiographical features, clinicopathological features, and treatment modalities of LELCC, with less than 28 cases of LE...

Descripción completa

Detalles Bibliográficos
Autores principales: Sam Saji, Alen, Yang, Biao, Hou, Wan Ting, Liu, Xia, Ren, Qiu Ping, Wei, Yuan Feng, Zhang, Yu Zu, Yang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971717/
https://www.ncbi.nlm.nih.gov/pubmed/36865802
http://dx.doi.org/10.3389/fonc.2023.1090580

Ejemplares similares

Ejemplares similares